Champions Oncology (CSBR) 10-Q2014 Q1 Quarterly report

Filed: 13 Sep 13, 12:00am

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. sophomore Avg

New words: absorption, employment, fixed, gene, implementation, independent, Inflation, iv, knowledge, leveraging, meaningful, medicine, mix, Mohamed, monthly, multiple, nil, President, Proxy, registered, renewed, rent, reserved, restructuring, Road, round, sell, sequencing, served, Sultan, twelve, upfront, Vice

Removed: administered, affordable, application, arising, ASU, attributed, audit, August, awarded, base, broader, certainty, Certification, Code, commenced, compared, comprised, conform, consultant, contract, contractual, CRO, decline, decreased, derive, Director, Discovery, Eligible, ending, examination, expanded, exposure, FASB, final, Flow, fourth, Grant, impairment, incidental, incur, individually, initially, initiation, intended, interim, intrinsic, involved, IRS, June, lab, litigation, maximize, month, notified, obtained, October, offset, ordinary, outcome, patent, patient, permitted, permitting, predicted, predictive, procurement, program, Project, prospective, Protection, Qualified, qualifying, qualitative, Recently, reduce, reduced, reimbursement, resulting, return, scope, selected, September, significantly, simplify, source, specific, standard, stockholder, substantial, Supplemental, test, Therapeutic, unit

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

CSBR similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

EXHIBIT 32.1

CERTIFICATION PURSUANT TO 18 U.S.C. SECTION 1350 AS ADOPTED PURSUANT TO
SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of Champions Biotechnology, Inc. (the “Company”) on Form 10-Q for the period ending July 31, 2013 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned, in the capacities and on the dates indicated below, hereby certifies pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to their knowledge:

The Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

The information contained in the Report fairly presents, in all material respects, the financial condition and results of operation of the Company.

Date: September 13, 2013	/s/ Joel Ackerman
	Joel Ackerman
	Chief Executive Officer (Principal Executive Officer)
Date: September 13, 2013	/s/ David Miller
	David Miller
	Vice President, Finance (Principal Financial Officer)

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.